KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Liabilities and Shareholders Equity (2016 - 2025)

Petmed Express has reported Liabilities and Shareholders Equity over the past 15 years, most recently at $88.0 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 39.25% year-over-year to $88.0 million; the TTM value through Dec 2025 reached $446.8 million, down 27.16%, while the annual FY2025 figure was $148.7 million, 12.47% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $88.0 million at Petmed Express, down from $100.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $187.5 million in Q1 2021 and troughed at $88.0 million in Q4 2025.
  • A 5-year average of $156.0 million and a median of $166.1 million in 2022 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 20.71% in 2021 and later tumbled 39.25% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $168.4 million in 2021, then grew by 0.7% to $169.6 million in 2022, then rose by 2.2% to $173.4 million in 2023, then fell by 16.47% to $144.8 million in 2024, then tumbled by 39.25% to $88.0 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for PETS at $88.0 million in Q4 2025, $100.3 million in Q3 2025, and $109.8 million in Q2 2025.